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ABSTRACT

Interactions of Burkholderia pseudomallei and Acanthamoeba castellanii
and their Effects on Virulence
in Human Monocytes

Emily A. Moore
Department of Microbiology and Molecular Biology
Master of Science
Burkholderia pseudomallei, the etiological agent of melioidosis, is a saprophytic
bacterium existing endemically in the water and soil of SE Asia and Northern Australia. This
organism has shown the ability to remain dormant in its host for decades. B. thailandensis is a
closely related non-pathogenic near neighbor that is also found in these soils. It has been
suggested that free-living amoeba could be natural reservoirs for these organisms. The
interactions of Burkholderia species and Acanthamoeba castellanii, a species of free-living
amoeba, were studied to better understand the natural ecology of these organisms and to
determine the effects amoeba interactions might have on pathogenesis. In this study, the
adherence and persistence of several B. pseudomallei clinical isolates were compared to that of
B. thailandensis within both amoeba and a human monocyte cell line. Results showed that B.
pseudomallei isolates can enter amoeba and survive therein at varying levels of efficiency. Some
isolates were able to persist inside the amoeba for up to three weeks. Optimal entry time into an
amoeba trophozoite was found to be about three hours for all ten B. pseudomallei isolates.
Interestingly, it was found that after internalization by amoeba, B. pseudomallei have a
significantly increased ability to both attach to, and grow within human monocytes, suggesting
that such interactions increase the virulence capabilities of soil isolates.
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INTRODUCTION
Microbiology
In 1911, the pathologist Alfred Whitmore and his assistant C.S. Krishnaswami, described a
glanders-like disease among morphia addicts in Rangoon, Burma that was later named
melioidosis (8). The etiological agent of melioidosis, Burkholderia pseudomallei, is a gramnegative, aerobic, motile saprophytic bacillus with one or more terminal flagella (44). In
Thailand, melioidosis is the third most common cause of death resulting from an infectious
disease following HIV/AIDS and tuberculosis (27). Clinical symptoms are extremely varied
making it difficult to diagnose.
These bacteria are particularly motile in the early stages of their growth cycle and measure
approximately 1.2µm in length (22). When stained, it has a bipolar appearance (44). This
disease was named from the Greek “melis,” meaning distemper of asses, and “eidos,” meaning
resemblance, by Stanton and Fletcher in 1932 (8). Over the years, this organism has been
variously known as Bacillus pseudomallei, Bacillus whitmorii, Malleomyces pseudomallei, and
Pseudomonas pseudomallei until in 1992, when it was finally changed to Burkholderia
pseudomallei (8). This organism is found in standing water, including 50% of rice paddies, and
soil, located usually at the rhizophere or root zone, in endemic regions (8, 11, 22, 44). This
bacterium grows best in soil which has a water content of 15% (3). As this organism is
commonly found in the water and soil, it has had to adapt to survive under very harsh conditions.
B. pseudomallei has been recovered from water sources ranging from pH 2-9 and is also able to
survive prolonged nutrient deficiencies, exposure to antiseptic and detergent solutions, a wide
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temperature range and dehydration, but is susceptible to killing by UV light (8). It has also been
isolated from the roots of plants and from distilled water ten years after inoculation (3).
When grown under laboratory conditions, the colonies vary morphologically. They are mostly
smooth in the initial growth stages on agar media, but can gain a rough, wrinkled appearance as
they are allowed to mature (8). Because this organism has significant bioweapon potential, it has
been categorized as a Class B select agent by the Centers for Disease Control and Prevention
(22, 36, 44). Other mammals susceptible to infection by this organism are: camels, horses,
sheep, cattle, goats, pigs, kangaroos, koalas, alpacas, deer, cats, dogs and captive marine animals
(8). Some animals are more susceptible to this type of infection than others.
Epidemiology
This organism is endemic in Southeast Asia, Northern Australia, South America and has been
described mainly in latitudes between 20°N and 20°S (8, 11). It has been described as an
emerging infectious disease in Brazil (4, 22). In Australia, the disease was first recognized in
sheep in 1949 in northern Queensland and it has been suggested that B. pseudomallei may have
colonized Australia from SE Asia (8, 11). In other endemic regions, this organism accounts for
approximately twenty percent of community acquired septicemias, and in Australia it has been
the most common cause of fatal community-acquired bacteremic pneumonia (8, 44). In these
endemic regions, about twenty-five percent of children will seroconvert every year during their
first four years of life (44). Recently reported disease incidence rates are 19.6 and 20.0 per
100,000 people per year in Northern Australia and Papua New Guinea, respectively (27).
Most cases that occur outside of these endemic areas are in travelers that have returned from
these regions (8). However, there have been two reported cases of melioidosis in North
2

America. One was an infection in Oklahoma after a farming accident and another was an
infection in Georgia after a motor vehicle accident. The Oklahoma isolate has been very well
studied and belongs to a distinct clade which could possibly represent a distinct species (22).
B. pseudomallei’s two closest near neighbors are Burkholderia mallei and Burkholderia
thailandensis. B. mallei, unlike B. pseudomallei, is non-motile and cannot persist in the
environment. It has a very restricted host range infecting mainly equine species and causing a
disease called glanders. It has been known to infect humans but usually only after contact with
infected equine species or pure cultures (22, 38). B. thailandensis is avirulent in animals and
humans, but is very similar to B. pseudomallei genomically (~90% sequence similarity) and
morphologically (36). One important phenotypic difference between the two species is the
ability of B. thailandensis to assimilate L-arabinose (17). B. thailandensis is also found in the
soil in B. pseudomallei endemic regions.
The genome of B. pseudomallei is quite large consisting of two circular chromosomes with a
combined length of 7.2Mb and an estimated 5800 genes (30). The first chromosome, 4.07 Mb,
has a high number of genes involved in core housekeeping functions such as: cell wall
biosynthesis, metabolism, nucleotide and protein biosynthesis, chemotaxis and motility. The
second chromosome, 3.17 Mb, codes more for accessory functions that could be related to
adaptation to environmental conditions (13). Multi-locus typing suggests that genomically B.
pseudomallei is more closely related to B. mallei then other near neighbors. This also indicates
that B. mallei evolved more recently than its other near neighbors and is most likely
representative of an adaption to a more specialized habitat (22). There are sixteen different
genomic islands throughout the genome of B. pseudomallei, indicative of significant horizontal
gene transfer which occurred both within B. pseudomallei strains and between B. pseudomallei
3

and other environmental bacteria (11). In addition, a number of drug resistance genes have been
identified (26).
Several risk factors for infection with B. pseudomallei have been identified: diabetes mellitus,
alcohol abuse, chronic renal disease and chronic lung disease (11). Melioidosis is most prevalent
in rice farmers, servicemen, miners, adventure travelers, and indigenous peoples in endemic
areas (22). There are three main routes of infection: inhalation, ingestion and inoculation
through breaks in the skin. Of these three routes, ingestion is the least common. Other rare
forms of transmission include person to person and one documented case of sexual transmission
(8). Higher numbers of cases are associated with heavy rainfall and flooding, indicating
involvement of environmental factors. Near drowning victims in these endemic areas also
frequently become infected with the organism, most likely because of the high inoculums inhaled
from water (8, 11). The peak season of melioidosis in Australia occurs two weeks after the
summer rainfall in the tropical northern regions (22). Two accounts of melioidosis outbreaks
due to contaminated water supplies have also occurred in Australia (34). Because of the high
levels of this bacterium in the rice paddies, farmers working with minor cuts or abrasions have
been known to become infected. There was also an incident of an inoculation which occurred
during a snake bite (8). The minimum infectious dose for humans has not been calculated, but
the LD50 for C57BL/BALB/c mice when inoculated intravenously was between 103 and 105
bacteria (22).
This organism exhibits a pattern of long periods of dormancy, the longest documented case being
62 years in a veteran from the second world war (13). B. pseudomallei can survive for months or
even years in the environment, which parallels its ability to reside in a dormant or quiescent state
in host cells and tissues such as human macrophages and lymph-reticular organs (22). This
4

disease has also been called the “Vietnam Time Bomb” because of the number of servicemen
that manifested the disease years after returning from Vietnam (22). It is suspected that large
numbers of organisms were aerosolized when helicopters flew close to the rice paddies (8).
Melioidosis manifests itself in a variety of symptoms, thus making it difficult to diagnose (5). It
often presents as a febrile illness and usually takes one of three courses in infection: a rapidly
progressing septicemia with or without pneumonia, a localized soft-tissue infection or a
subclinical infection with delayed conversion to a clinically evident infection (22, 44). It
frequently forms abscesses, especially in the lungs, liver, spleen, skeletal muscle and prostate.
Four percent of patients will present with brain stem encephalitis (44). The lung is the most
commonly affected organ, with either a cough and fever resulting from a primary lung abscess or
pneumonia, or secondary to septacaemic spread. Sputum is purulent (44). A central nervous
system infection is another rare clinical manifestation with a high mortality rate that occurs more
commonly in Australia (22). The mortality rates are about 50% in Thailand and 20% in
Australia, most likely due to better treatment facilities and programs in Australia (27, 44). The
most common symptoms in endemic regions are also different, with acute suppurative parotitis
being a unique syndrome found in children in SE Asia and prostatitis being more common in
Australia (44). The major cause of death resulting from this infection is usually severe sepsis
and organ failure (27).
Treatment
While melioidosis is a treatable disease, a very rigorous course of antibiotics is required. This is
because B. pseudomallei is resistant to many common antibiotics and it also has the ability to lie
dormant for many years making it difficult to completely eradicate (35). B. pseudomallei is
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resistant to: third generation cephalosporins, penicillins, rifamycins, and most aminoglycosides.
It also has relative resistance to quinolones and macrolides (8). On the other hand, B.
pseudomallei is susceptible to kanamycin and also to ceftazidime which is usually the drug of
choice (8, 44). Melioidosis is also commonly treated with a four drug regimen of
chloramphenicol, doxycycline, and trimethoprim-sulfamethoxazole. In cases involving children
or pregnant women, a treatment with amoxicillin-clavulanate is preferred. High dose parenteral
treatment with antibiotics is administered for at least ten days, followed by a switch to oral
antibiotics only after there is a clear sign of improvement of clinical symptoms. Usually,
chloramphenicol is given for the first eight weeks of oral treatment, followed by the addition of
doxycycline and cotrimoxazole for a full twenty week regime (44). Even after this intense
treatment, ten to twelve percent of patients will relapse (44). Other treatment options such as
antimicrobial peptides are currently being explored (23).
Virulence Factors
Secretion Systems
B. pseudomallei has many virulence factors in its large genome, which contribute to its
pathogenesis. While not all of these virulence factors are well described or understood, some are
much more proven. Many gram negative bacteria, such as B. pseudomallei, have a Type 3
Secretion System (T3SS) which allows them to inject virulence factors directly into the host cell.
Often times, a T3SS is acquired through horizontal transfer (39). The proteins injected by a
T3SS interfere with or block host immune responses, thereby helping the bacteria to invade host
cells. There are many different organisms which possess T3SS, such as Pseudomonas, Yersinia,
Salmonella and Burkholderia. Among these various organisms, the structure and function of the
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T3SS is conserved. It consists of about 20 different proteins, most of which are involved in
constructing the macromolecular complex which spans the inner bacterial membrane, the
periplasmic space, the peptidoglycan layer, the outer bacterial membrane, the extracellular space
and the host cellular membrane. This complex structure houses a needle complex also referred
to as the injectisome, which is used to inject various effector proteins into the host (29).
B. pseudomallei has genes coding for three T3SS. Two of these are very similar to the plant
pathogen-like T3SS of Ralstonia solanacearum and it is believed that they are involved in
symbiotic or even pathogenic bacteria-plant interactions in rice paddies. The third T3SS is
called Burkholderia secretion apparatus (Bsa) and it resembles the Salmonella enteric serovar
Typhimurium pathogenicity island I (17). So far 9 B. pseudomallei effector proteins have been
described, one of which is bobE which is a homolog of the Salmonella SopE (17). The full
involvement of the T3SS in virulence of B. pseudomallei is not entirely understood, but it is clear
that it is necessary.
B. pseudomallei also has six Type 6 Secretion Systems (T6SS) genes in its genome. Many other
pathogenic organisms have a T6SS, such as Vibrio cholera, Yersinia pestis, Francisella
tularensis, Burkholderia mallei, Salmonella typhimurium, pathogenic Escherichia coli, etc. The
T6SS loci usually contain 15-25 genes (32). The majority of T6SS components that have been
studied so far are not secreted, but they are necessary for the secretion of hemolysin coregulated
protein and the valine-glycine repeat protein G (32). In one of the T6SS in B. pseudomallei, the
expression of three genes is induced following macrophage invasion, but there is not a lot known
about their roles in virulence (2).
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Siderophore and Biofilms
B. pseudomallei possesses a siderophore to sequester iron for growth. This siderophore is called
malleobactin, and it is very efficient at acquiring iron in an acidic pH. It is regulated by the fur
gene which also regulates superoxide dismutase and peroxidase (8).
B. pseudomallei produces a biofilm which aids in the infection process, but does not appear to be
essential for virulence. It is more likely that it plays a role in environmental survival (2). In the
biofilm, there are slow growing bacteria within an extracellular polysaccharide matrix in a very
complex three-dimensional structure. The production of biofilm is controlled by quorum sensing
and biofilms have been observed in infected lung tissue from guinea pigs and humans (22).
Quorum sensing is a means of cell-to-cell communication based upon cell density (2). RpoE is
an alternate sigma factor that is involved in biofilm production and in RpoE mutants, there is a
50% reduction in biofilm production.
Adhesion
The polysaccharide capsule is believed to help B. pseudomallei in attachment to various host
cells. There are three different varieties of capsules produced by B. pseudoamallei. One is a
macrocapsule which is approximately 0.1-0.25µm in thickness, the second, a microcapsule of
0.086µm in thickness and lastly, there are some isolates that have no capsule (2). The capsule
also aids in protecting the bacteria from opsonization, resulting in a decrease in phagocytosis and
thus a hindered ability of the host to clear the infection. The capsule can also act as a barrier by
blocking the access of the CR1 receptor on phagocytes (33). There is evidence that after the
bacterium is internalized, it sheds its capsule.
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Both flagella and pili have also been shown to aid in cell attachment (13). B. pseudomallei has
flagella and type IV and Tad-like pili expressed on its surface (13). This organism has two to
four polar flagella which provide motility independent of temperature. A gene required for
flagella production is the fliC gene which encodes a 39.1-kDa protein. Antiserum against this
gene product was able to block motility in almost all isolates examined (2).
Lipopolysaccharide (LPS)
Altering the LPS structure is a common evasion strategy of bacteria to avoid pattern recognition
and other immune receptors of host cells (16). B. pseudomallei adapted this strategy with a
unique, acid-stable structure between the inner core and lipid A linkage, along with longer
amide-linked fatty acids. The longer fatty acid chains are predicted to decrease the level of
recognition by CD14 on the surface of macrophages which in turn leads to a reduced
inflammatory response. Other bacteria that are known to employ similar modifications are
Proteus, Salmonella, E. coli, Serratia and Pseudomonas (16). In the absence of this unique LPS,
there is an increase in IFN-β stimulation (2).
There have been three different B. pseudomallei LPS types described: two smooth serotypes A
and B and one rare rough serotype. Serotype A accounts for 97% of strains, while the other two
serotypes have been associated with strains that cause a disease relapse. No immunological
cross reactivity among the varying serotypes has been described (2). High concentrations of LPS
antibodies have been shown to improve survival in melioidosis patients. The LPS of both B.
pseudomallei and B. thailandensis activates hTLR 4 (31).
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Immune Response
B. pseudomallei is a facultative intracellular pathogen able to attach, invade and multiply within
neutrophils, monocytes and macrophages without eliciting a strong immune response. Prior to
invasion, B. pseudomallei activates the alternative pathway of complement and is phagocytosed;
however, it is resistant to lysosomal defensins and cationic peptides. After phagocytosis, the
T3SS delivers various effector proteins to the host cell, which can assist in vacuolar escape and
intracellular motility. It is able to escape the phago-lysosome, as soon as fifteen minutes after
ingestion, and it can replicate both intracellularly and extracellulary (2, 8).
Toll-like receptors (TLR) recognize various pathogen associated molecular patterns (PAMPs)
from B. pseudomallei such as LPS and flagellin. MyD88 plays a role in the host immune
response to melioidosis by activating TLRs. In patients suffering from septic shock, an increase
in the activation of TLR1, TLR2, and TLR4 and its coreceptor CD14 has been described and
macrophage-mediated killing of B. pseudomallei is due mainly to reactive nitrogen intermediates
(RNI) (2). TLR2 has been associated with the growth and dissemination of B. pseudomallei
throughout the body and it especially contributes to organ injury (45). The activation of TLR2
and TLR4 induces recruitment of various immune cells such as neutrophils, macrophages and
NK cells (16). Proinflammatory cytokines are released and bacteria begin to replicate. B.
pseudomallei can escape the cell by inducing apoptosis which can then lead to a secondary
infection. B. pseudoamllei can cause apoptosis of macrophages and caspase-1-dependent cell
lysis (2).
B. pseudomallei spreads from cell to cell through actin-mediated motility. It uses host actinassociated proteins to polymerize actin and move between cells. BimA, a protein secreted by B.
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pseudomallei, interacts with actin and localizes it at the bacterial pole. Mutants of bimA are
unable to polymerize actin. Because of its use of actin, B. pseudomallei can fuse host cells
together creating multinuclear giant cells (MNGC) (19).
After initial infection, bacteria are able to spread to secondary sites, such as the spleen or liver.
Inflammation allows increased access to the circulatory system, and although the exact
mechanism of secondary spread is not known, it is possible that the bacteria use macrophages
and the lymphatic system to migrate to other locations within the host (2). Relapses of
melioidosis are common among those infected, although the exact mechanisms involved in
latency and reactivation are not fully understood.
Free-living amoeba
Free-living amoeba are aerobic, mitochondriate, eukaryotic protists that can be found throughout
the world naturally in various environments. Some examples are Acanthamoeba spp.,
Balamuthia mandrillaris and Naegleria fowleri, all of which can cause opportunistic disease in
humans. The prevalence of human infections is not very high and thus, no efforts have been
made to control free-living amoeba in the environment (46). These amoeba are ubiquitous and
are found in many different environments around the world. They have been isolated from many
different sources such as: soil, fresh and brackish waters, bottled mineral water, cooling towers
of electric and nuclear power plants, heating, ventilating and air conditioning units, humidifiers,
Jacuzzi tubs, hydrotherapy pools in hospitals, dental irrigation units, dialysis machines, dust in
the air, bacterial, fungal and mammalian cell cultures, contact-lens paraphernalia, ear discharge,
pulmonary secretions, stool samples, etc (14, 43). The ability to act as parasites within host
tissues has resulted in these organisms being referred to as amphizoic amoebae (43).
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Acanthamoeba spp. along with Balamuthia can cause a chronic and mostly fatal disease known
as granulomatous amoebic encephalitis (GAE). The onset of this disease is slow and can
develop as a chronic illness over weeks or even years. The most common symptoms of GAE are
headache, stiff neck, and mental-state abnormalities. Other symptoms can also include nausea,
vomiting, low-grade fever, lethargy, cerebellar ataxia, visual disturbances, hemiparesis, seizures
and coma (43). This disease is most commonly found in those that are immunocompromised.
Since the infections caused by these amoeba are rare, they are often hard to diagnose, and
therefore many are confirmed during autopsy. The number of cases worldwide is not accurately
known because of the lack of accurate diagnosis and reporting in many areas where infections
occur.
Acanthamoeba can also cause keratitis, an inflammation of the cornea, which can lead to vision
impairment (43). This disease is associated with trauma to the cornea or use of contaminated
contact-lens products. Severe inflammation occurs along with photophobia, ocular pain and a
360° or paracentral stromal ring infiltrate. Generally speaking there is only one eye that is
affected, but cases of bilateral keratitis have been documented. People who wear contact lenses
are a risk group and it is estimated that as of August 2006 there were more than 5,000 reported
cases in the United States alone (43). Unfortunately, there are not very effective treatments
available for the various diseases caused by these species (14, 28).
Acanthamoeba castellanii was isolated in 1930 by Castellani after whom the species was named.
It was isolated as a contaminant from a yeast culture plate and classified under the Super Group
Amoebozoa. Within this class, there are more than 24 different species of Acanthamoeba.
These organisms are classified into three main groups based on morphological criteria and cyst
size (43). Group I includes species which have large amoebae with cysts that are approximately
12

16 to 30µm in size. The next group has the largest number of species with cysts measuring
approximately 18µm or less. The third and final group contains species with the same cyst size
as Group II, but with slight morphological differences (43). Through evolutionary studies and
examination of rRNA genes, there have been fifteen different genotypes identified among these
species (28). It has been shown that about 90% of the infectious Acanthamoeba isolates belong
to the T4 genotype.
Acanthamoeba species have two main stages in their life cycle, a vegetative or trophozoite stage
and a dormant cyst stage. During the trophozoite stage, the organisms are quite active and feed
on bacteria and detritus that are present in the surrounding environment. Free-living amoeba in
the trophozoite stage are phagocytic and can engulf entire bacterial cells (46). They reproduce
through binary fission. Morphologically, Acanthamoeba spp. can be identified distinctly by their
fine, tapering, thorn-like acanthopodia that arise from the surface of the body. In the trophozoite
stage, the amoeba can range from 15 to 50µm in size, depending on the particular species (43).
Amoeba form a cyst during periods of nutrient deficiencies, desiccation and other environmental
stressors. While the amoebae are in the cyst stage, they are dormant. The cyst gives the amoeba
added protection from various chemicals, and temperature and pH extremes, much like a spore
does for a bacterium (24). These cysts are double-walled and can range in size from 10 to 25
µm. The ecocyst is the outer wall which contains lipids and proteins, and is wrinkled with folds
and ripples. The endocyst or inner wall contains cellulose and can vary in shape (6, 43). The
cysts are uninucleate and have a centrally placed very dense nucleolus. When favorable
conditions return, the trophozoite stage is activated and they leave the cyst.
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Amoeba-Bacteria interactions
Amoeba species exist in the soil and water where they interact with many types of bacteria. This
provides a selective environment in which these bacteria evolve the ability to evade amoeba
predation (1). Many bacteria have shown the ability to adhere to, enter, and survive inside of
amoeba, and use the amoebal cysts to prolong their survival. Free-living amoeba have been
described as interacting with: Legionella pneumophila, Mycobacterium avium, Chlamydia,
Francisella tularensis and Rickettsiae (46). There have also been examples of amoeba-bacterial
endosymbiotic relationships. In one instance, Amoeba proteus became dependent on its bacterial
symbiant due to essential modifications in the gene expression of the symbiotic bacteria (46). It
is also possible that these relationships could be used by the bacteria as a means of transmission.
Bacteria have been observed in amoeba trophozoites and cysts. A study showed that when an
Acanthamoeba trophozoite encysts, it produces a membrane-surrounded vesicle that can be filled
with bacteria, and both the bacteria and the amoeba could be easily spread in an aerosol. The
bacteria are usually found in the contractile vacuoles in the amoeba, but have also been observed
in the cytosol (19).
There are clearly some advantages to the bacteria from bacteria-amoeba interactions. For
example, L. pneumophila upon growing in A. castellanii has a shorter generation time, altered
morphology, different surface properties and an increased invasiveness in macrophages and
epithelial cells, along with increased virulence in experimental animals (9, 46). The bacteria also
showed large vesicles in their cytoplasm and were able to express five new proteins after amoeba
exposure. Another bacterium, Vibrio mimicus, increased in numbers tenfold in the presence of
A. castellanii, and was able to survive longer then bacteria growing alone (1). Most of these
organisms were found to be in the cytoplasm of the amoeba trophozoites after one and three days
14

of incubation, and were also observed in cysts at the same time points (1). As the amoeba were
encysting, the bacteria were found in a space between the ecto- and mesocyst after three days of
incubation in co-culture. This cyst stage allowed the bacteria to survive for more than two weeks
in the amoeba. This same pattern was seen with several other bacteria including B.
pseudomallei. Because of the resistance of cysts to harsh environmental conditions, they give
extra protection to any bacteria residing in the amoeba (1). V. mimicus was also able to survive
inside encysted amoeba after a gentamicin treatment at a concentration of 1,000µg/ml.
A. castellanii is found endemically in the soil and waters of SE Asia, an endemic region for B.
pseudomallei, thus creating an environment conducive to frequent interactions between these two
organisms (20, 37). B. pseudomallei has been shown to enter and survive inside of amoeba.
When the bacteria adhere to amoeba trophozoites, a rapid rotation was observed, indicating a
possible role of the flagella in adhesion. It uses a coiling phagocytosis mechanism to enter the
host cell. This same mechanism of phagocytosis has been observed to occur between L.
pneumophila and both Acanthamoeba spp and human monocytes (20). There are various species
of free-living amoeba that B. pseudomallei can enter: Acanthamoeba astronyxis, A. castellanii,
A. palestiniensis and A. polyphaga (22). Once the bacteria are phagocytosed, they are able to
escape from the vacuoles and enter the cytoplasm. After a 24 hour co-culture of A. astronyxis
and B. pseudomallei, extracellular bacillary tufts and tangles were observed entangling the
amoeba (20).
Inglis et al. also noticed varying responses among the different species of Acanthamoeba when
co-cultured with B. pseudomallei. Vacuolation was less pronounced in A. castellanii and A.
polyphaga when compared with A. astronyxis. Also, no external bacillary tufts were observed in
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the first two species when incubated at 20°C, but the initial phagocytosis and bacillary tangles
were more readily observed when co-cultures were incubated at 37°C (20).
Near neighbor B. cepacia has also been described as being able to survive, but not replicate
within vacuoles of A. polyphaga, murine macrophages, and in a human monocyte cell line (25).
It was observed that infected phagocytes, whether macrophages or amoeba, that contained
intracellular bacteria eventually died. It was also found that the bacteria only replicated
extracellulary and could be found within an acidified membrane-bound compartment which is
separate from the phagolysosome. B. cepacia was, like many other bacterial species, able to
survive for extended periods of time inside amoeba and macrophages: seventeen and six days,
respectively (25).
The ability of B. pseudomallei to lay dormant for long periods of time can possibly be attributed
to its ability to survive in human macrophages and avoid destruction (20). These mechanisms
could be primed and developed in free-living amoeba. It is possible that similar methods of
phagocytosis are employed by amoeba and human monocytes, although coiling phagocytosis of
B. pseudomallei in human monocytes has not yet been observed (20). The relationship of B.
pseudomallei and Acanthamoeba that has been described is very similar to that of Legionella and
Acanthamoeba. Legionella has a symbiotic relationship with the free-living amoeba, and it is
possible that B. pseudomallei is developing a similar relationship, and may use the amoeba as a
reservoir in endemic areas (20).
Although it has been previously discovered that B. pseudomallei can enter free-living amoeba, it
has not been quantifiably examined. It is important to gain a better understanding of this
relationship and its effects on the virulence of this organism. The mechanisms these bacteria use
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to adhere to, enter, and proliferate inside amoeba are the same mechanisms that are needed for
entrance and survival inside mammalian cells (20, 46). L. pneumophila intra-amoebal
interactions have been shown to enhance entry and virulence in human monocytes (20).
We hypothesize that there will be a diversity of virulence among various B. pseudomallei
isolates relative to amoeba infections. Also, it is anticipated that B. thailandensis will have a
lower response in all three indicators of virulence, especially optimal entry time, when compared
to B. pseudomallei. In long-term survival, B. pseudomallei should be able to survive for weeks
regardless of encystment of amoeba. In this study we show that B. pseudomallei clinical isolates
can also adhere to, enter, and survive inside amoeba at varying efficiencies and that virulence in
human monocytes is increased after being passaged inside amoeba.

MATERIALS AND METHODS
Strains and growth conditions. Burkholderia pseudomallei and Burkholderia thailandensis
strains were obtained from various locations (Table 1). All isolates were grown on Columbia
agar plates at 37°C or in Brain Heart Infusion broth with aeration at 37°C.
Cell lines and culture conditions. Acanthamoeba castellanii ATCC 30234 was grown in
Peptone Yeast Glucose (PYG) broth (2% proteose peptone, 0.1% yeast extract, 0.1% sodium
citrate, 1% 0.4M magnesium sulfate, 0.8% 0.05M calcuium chloride, 1% 0.005M ferrous
ammounium sulfate, 1% 0.25M dibasic sodium phosphate, and 1% 0.25M monobasic potassium
phosphate) in the dark at 25°C until confluent in 75-cm2 culture flasks (Corning). To harvest,
the sides of the flask were rapped sharply to remove adherent amoeba which were then
suspended in fresh media. Cell counts were determined using a hemacytometer.
17

Entry and adherence assay. In brief, 1ml of A. castellanii trophozoites were seeded into a 24well plate (Corning) at a concentration of about 2 x 105 per well and allowed to incubate
overnight in the dark at a temperature of about 25°C in PYG broth. The PYG broth was then
removed and replaced with a High Salt buffer (HSB) (0.1% sodium citrate, 1% 0.4M magnesium
sulfate, 0.8% 0.05M calcuium chloride, 1% 0.005M ferrous ammonium sulfate, 1% 0.25M
dibasic sodium phosphate, and 1% 0.25M monobasic potassium phosphate) and the plate was
allowed to incubate for 1h at 37° C. Each well was then infected with 100µl (multiplicity of
infection (MOI) ~100) of an overnight bacterial culture and returned to incubate for 30 min. For
cell adherence, the cells were washed twice with HSB, lysed with 0.5% Saponin, and then plated
using a Millipore Manifold filtration system. For entry assays, cells were washed once and then
the media was replaced with HSB containing 250µg/ml Kanamycin (Sigma Aldrich). Cells were
incubated for 2 hr, washed once with HSB, lysed with 0.5% Saponin, and plated in a similar
manner as described above.
Intracellular survival assay. The assay was begun as previously described and the cells were
washed once with HSB after the antibiotic incubation period. Fresh HSB was then added and the
plate was returned to the incubator for approximately 24 hr under the aforementioned conditions.
Amoeba were then lysed and the lysate was plated as previously described.
THP1 Infection with amoeba-passaged bacteria. Bacteria were passaged with amoeba as
described above for a 24 hr infection. After incubation, 0.5% Saponin was added to each well,
the lysate was removed to an eppendorf tube, bacteria were collected by centrifugation and
washed twice with RPMI. The resulting suspension of bacteria was used to infect THP1 cells.
Overnight cultures of the same isolates were used to infect THP1 cells as controls.
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Eppendorf tubes with 1 ml of 106 THP1 cells were incubated at 37°C and 5% CO2 for 10 min.
Cells were infected with bacteria at an MOI of ~100, in triplicate. The tubes were then incubated
in the same conditions for 30 min and washed twice with PBS. For cell association assays, the
cells were lysed with a 0.5% Saponin solution followed by plating of serial dilutions in duplicate.
For entry and 24 hr assays, cells were washed with PBS, and then re-suspended in 1 ml of media
with 250µg/ml kanamycin. This was followed by a 2 hr incubation under the same conditions.
The entry assay cells were washed once with PBS, and the cells were lysed and plated as
previously described. After 24 hr, the remaining cells were lysed and plated.
Long-term amoeba survival assays. Amoeba were seeded into a 6-well plate (Corning) at a
concentration of 2 x 105 amoeba/ml with 3ml/well and allowed to adhere for 24 hr. The media
was replaced with HSB and the wells were incubated at 37 °C for 1 hr. The amoeba were
infected at an MOI of ~100 and returned to the incubator for 30 min. The HSB was replaced
with a 250µg/ml kanamycin solution in HSB for 2 hr. The cells were washed once with HSB
and 3 ml of fresh HSB was added before the plates were incubated for various survival times.
When the time point was reached, the HSB was removed and replaced with 3 ml of amoeba
medium. The co-cultures were then allowed to incubate for 72 hr or until turbid, whichever
happened first. The positive cultures were gram stained for confirmation of B. pseudomallei
growth.
Long-term survival assays in the absence of amoeba encystment. The protocol described
above was repeated except, 25 µg/ml cycloheximide was added in addition to the kanamycin
treatment to prevent encystment of the amoeba. One hour before the HSB was changed to
amoeba media, another cycloheximide treatment was performed. The co-cultures were then
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allowed to incubate for 72 hr or until turbid, whichever happened first. The positive cultures
were gram stained for confirmation of B. pseudomallei growth.
Statistical analyses. Bacterial count data for the 3 hour, amoeba, and THP1 studies were
analyzed using generalized linear mixed models. Computations were done with the GLIMMIX
procedure of SAS 9.2, using the maximum likelihood fitting method. Counts were assumed to
follow the Poisson distribution, and a linear function of predictor variables was linked to the
mean of the Poisson distribution via the logarithmic function. Dilution factor and titer were
included as an offset in the model. The linear predictor included fixed effects for organisms,
treatments, and hours as appropriate for the study. In all studies, the linear predictor also
included random effects for replications and tubes within replications. Residual plots as well as
the Pearson chi-square ratio were used to assess goodness-of-fit of the model. Pairwise
differences between levels of fixed effects were tested using Wald tests.
The same model was used for bacterial counts in the entry study except that the bacterial counts
were modeled as following a Negative Binomial distribution due to the presence of some
extremely high counts.
RESULTS
B. pseudomallei can adhere to, enter, and survive inside amoeba at various efficiencies. To
determine the ability of B. pseudomallei to enter and survive inside of amoeba, we infected
amoeba with ten clinical isolates selected from various geographical regions and times (see
Table 1). The avirulent near-neighbor, Burkholderia thailandensis, was included for
comparison. Results showed that B. pseudomallei was able to associate with, enter and survive
inside A. castellanii with varying efficiencies, depending on the isolate (p < 0.01) (Fig 1). In
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comparison, B. thailandensis was significantly less efficient (p < 0.01) at associating with,
entering and surviving in amoeba.
B. pseudomallei PHLS 35, was the most efficient at attaching to the amoeba. It displayed a 60%
association rate which was more than double the next highest isolate. PHLS 9 and 13178 were
the least efficient B. pseudomallei isolates at attaching to the amoeba (Fig 1A). However, they
were significantly better than the avirulent B. thailandensis control. Interestingly, isolate 13178
was one of the least efficient at associating with the amoeba, but it was one of the most efficient
at entering the cells. The other two most efficient isolates in cell entry were PHLS 6 and PHLS
35 (Fig 1B). Again, the avirulent B. thailandensis had the lowest level of cell entry. In survival
inside amoeba, there was one isolate that performed significantly better than the others. B.
pseudomallei PHLS 6 was by far the most efficient survivor, with almost 80% of the cells
surviving inside the amoeba at 24 hr. The other isolates averaged only about a 10% survival.
Again, B. thailandensis had one of the lowest survival percentages (Fig. 1C).
B. pseudomallei enters A. castellanii optimally at 3 hours. In order to examine the entry
kinetics of B. pseudomallei into the amoeba, A. castellanii cells were infected with B.
pseudomallei 13178 and B. thailandensis ATCC 700388 as a control. The co-cultures were
allowed to incubate for 1, 2, 3, and 4 hours, to ascertain the optimal time for the largest entry
percentage (Fig. 2). While there was a slow steady increase of B. pseudomallei entering the
amoeba from 1 to 2 hr, there was a 20 fold entry increase from 2 to 3 hr. The rate of increase
from 3 to 4 hours slowed to just slightly more than that of the 1 to 2 hour period. In comparison,
the avirulent B. thailandensis showed a very low ability to enter this species of amoeba, with no
entry seen until 3 hr of co-culture. The rate of entry from 3 to 4 hours was slightly lower than

21

the rate of B. pseudomallei from 1 to 2 hr, achieving only about a 0.2% cell entry after 4 hr of coculture.
B. pseudomallei isolates differ widely with respect to 3 hr entry percentages. Since the entry
kinetics data for B. pseudomallei 13178 showed that three hours was the optimal amoeba entry
time, experiments were undertaken to obtain similar data for the other nine B. pseudomallei
isolates. After repeating the entry assay with all ten isolates using a three hour contact time,
results showed significant variability in the entry abilities of the 10 isolates (Fig. 3). B.
pseudomallei 13178 entered amoeba significantly better than PHLS 6, which entered
significantly better than the remaining isolates. It is important to note that even the B.
pseudomallei isolates with the lowest entry percentages (PHLS 35 and Darwin 2) were
significantly better than the avirulent B. thailandensis isolate. The fact that PHLS 35 had one of
the lowest entry percentages at 3 hr was surprising, especially since, as previously shown, PHLS
35 was one of the more efficient isolates at associating with amoeba and entering during a
shorter incubation time.
B. pseudomallei is able to survive in A. castellanii for up to three weeks without encystment.
To better understand B. pseudomallei’s ability to survive long-term within amoeba, A. castellanii
cells were incubated for up to three weeks while being suspended in HSB. Amoeba were
infected with an overnight culture (MOI ~100) and treated with kanamycin after a 30 min
incubation period. Cells were then washed and replaced with fresh HSB. The HSB allows
survival of the amoeba, but does not promote bacterial growth.
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Five representative isolates (B. pseudomallei PHLS 6, PHLS 9, 13178, 80800117 and B.
thailandensis 700388) were selected to infect the amoeba. Results showed that all 5 isolates
were able to survive for up to three weeks in A. castellanii (Table 2).
B. pseudomallei does not require encystment to survive long-term in amoeba. To determine
whether encystment was required for survival of the bacteria, the previous co-culture experiment
was repeated with the addition of cycloheximide in addition to the kanamycin, and an additional
1 hr treatment of cycloheximide to prevent encystment before adding PYG media. Results
showed that encystment was not required for the B. pseudomallei to survive (Table 2). All five
isolates, including B. thailandensis, were able to survive for up to three weeks in HSB, even
without the protection of amoebal cysts.
B. pseudomallei is more virulent after being passaged in amoeba. Since data from previous
studies using different pathogens indicated that virulence was increased by passage through
amoeba, experiments were performed to assess these effects using B. pseudomallei. Cell
association, entry, and survival of B. pseudomallei 13178 and B. thailandensis ATCC 700388
were assessed for the human monocyte line THP1s. These bacteria were used to infect the
monocytes both before and after passage through A. castellanii amoeba.
There was a striking difference in all 3 assays between cultured bacteria and amoeba-passaged
bacteria for both B. pseudomallei and B. thailandensis (Fig. 4 and 5). The non-passaged bacteria
were only about 8% efficient at associating with the amoeba, whereas the amoeba-passaged
bacteria were close to 100% efficient at attaching. This same trend continued in the other two
aspects, entry and survival. Interestingly, amoeba-passaged B. thailandensis had higher values
(almost double) in all three assays when compared to amoeba-passaged B. pseudomallei (Fig. 5).
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DISCUSSION
B. pseudomallei has a large genome and demonstrates a high degree of variance among clinical
isolates, which most likely factors into the observed variability in virulence. It has been
suggested that B. pseudomallei is an ‘accidental pathogen’ that most likely gained virulence in its
natural soil environment, possibly through several horizontal transfer events, during interactions
with free-living amoeba and other soil protozoa (20, 30, 37, 41). Amoeba share many
characteristics with macrophages, the cells that first encounter many bacterial invaders (20, 46).
By studying the interactions between B. pseudomallei and the common soil amoeba A.
castellanii, insights into both the natural ecology of this bacterium and how it interacts with the
innate immune system can be obtained.
Due to the variability in virulence among B. pseudomallei isolates, ten different isolates were
selected to cover this variability (30, 41). The isolates for this study were selected based on
location and date isolated, to maximize variation. All isolates are from human cases to ensure
that they are indeed virulent and can cause disease. Many of these isolates have been used in
previous studies and are believed to represent the virulence characteristic of this species (15, 40,
42).
Using the indicators of cell association, entry, and survival to measure virulence, it was found
that the ten virulent B. pseudomallei isolates studied produced widely varied indices. Variation
within a species is expected, especially for one with such a large genome like B. pseudomallei.
The avirulent, near neighbor, B. thailandensis, not surprisingly, was not as adept at attaching,
entering and surviving inside the amoeba. This is most likely because of its loss of certain
necessary virulence factors that enable bacteria to infect and replicate in both protozoa or
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mammalian cells. El-Etr et al. found, when comparing various Francisella tularensis isolates,
that this species also had varying abilities to attach, enter, and survive in amoeba (12). The
avirulent control in this study, the live vaccine strain (LVS), was statistically lower in these
measures of virulence, similar to the responses of B. thailandensis in this study. Both
Burkholderia and Francisella isolates are commonly found in the soil and water where amoeba
are naturally present. Therefore, one would expect that these bacteria have evolved and adapted
ways to avoid predation by amoeba, and maybe also have simultaneously acquired mechanisms
to avoid destruction by mammalian immune cells. Other studies, using various amoeba species
and Burkholderia species, have shown interaction among the two organisms (20-21, 25). These
studies also showed that Burkholderia spp. interact with amoeba and are capable of surviving
inside free-living amoeba.
The amount of time it takes bacteria to invade an amoeba is a probable indicator of virulence.
Results from these studies indicated that three hours was the optimal time to measure entry of B.
pseudomallei into the amoeba. Other species, such as S. aureus, show an optimal entry time of
about 5 hr with A. polyphaga, while M. avium peaks at about 5 days of co-incubation with A.
castellanii (10, 19). The B. thailandensis control was significantly lower than all ten B.
pseudomallei isolates studied, indicating its lack of key virulence factors. Even though all of the
isolates were not as effective as the standard B. pseudomallei 13178, even the least virulent B.
pseudomallei was significantly higher than B. thailandensis at all four time points. Therefore,
these assays seem to be a simple and effective way to quantitatively test for virulence in these
species.
Many bacteria, after growing in the presence of amoeba, are more virulent in mammalian cells
(9, 20, 46). It is possible that invasion of amoeba prime the expression of traits that allow
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increased virulence in mammalian cells. B. pseudomallei and Acanthamoeba species, co-exist in
the soil and therefore have had extensive opportunities to co-evolve. Free-living amoeba exhibit
similar behavior to certain innate immune cells which operate in mammals (i.e. macrophages)
(7). This may have provided B. pseudomallei a head start in adapting to the immune system of a
more advanced host.
In a recent study, it was shown that B. pseudomallei can more efficiently adhere to and enter a
human epithelial cell line compared to B. thailandensis (7). It was also shown that B.
pseudomallei was able to survive and replicate inside of primary human monocyte-derived
dendritic cells and macrophages, and that B. pseudomallei and B. thailandensis demonstrated a
similar ability to survive, but only B. pseudomallei was able to replicate (7). The results of our
experiments were similar in that both were able to survive, but no replication was observed.
Howard et al. also showed that B. pseudomallei virulence was enhanced after passaging through
A. astronyxis, a different species of Acanthamoeba (18).
While increased virulence response was an expected result, the intensity of the response was
unexpected. Cell association and entry assays, especially, showed more replication when
compared to those using non-passaged bacteria. A possible explanation for this response, could
be due to MOI. Amoeba have a finite number of cell surface receptors. Thus, according to the
Poisson distribution, the higher MOI (used with the non-passaged bacteria) would result in a
smaller number of bacteria that could invade a cell, while the lower MOI (used with the amoebapassaged bacteria) would result in almost every bacterium being able to attach. Interestingly, B.
thailandensis, after being passaged through amoeba, was able to associate with, enter, and
replicate within a human monocyte line to a higher degree than B. pseudomallei. This is
unexpected and opposite of what has been previously described (12). These two species are
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found together in the same environments with amoeba, so it is possible that B. thailandensis,
while non-pathogenic, has evolved mechanisms to survive within amoeba that are of increased
benefit in this monocyte line. The percent survival results in THP1 cells were not particularly
informative, probably due to the fact that the bacteria released from dead monocytes were able to
grow unrestricted during the 24 hour incubation. This experiment needs to be repeated in an
environment which does not support the growth of bacteria.
Encystment of amoeba trophozoites is rapidly induced by stress. Since the cyst provides notable
protection from harsh environmental conditions, some bacteria have exploited this defense for
their own protection and survival (12). B. pseudomallei, however, does not require a cyst to
survive, which is not true for other more fastidious species, such as Francisella (12). Both
organisms are able to survive up to three weeks in amoeba cysts, but when encystment is
blocked, only Burkholderia spp. are able to survive for the same amount of time (Table 2).
Another difference between these two systems is that B. thailandensis was able to survive
without encystment, whereas F. tularensis LVS was unable to do so. Because B. thailandensis is
a natural saprophytic organism found in B. pseudomallei endemic regions, it is not surprising that
it was able to survive for an extended period of time inside the amoeba, where the laboratory
created avirulent LVS could not. B. pseudomallei is capable of entering amoeba and it has been
observed within both the cyst and trophozoite stage (18). Encystment of amoeba was observed
during co-culture, especially after 24 hours. The exact role encystment plays in the natural
survival of Burkholderia species in the environment remains to be determined.
Using free-living amoeba as an infection model for B. pseudomallei seems simpler and easier
than some of the models that have been recently described. Some current models include
BABL/c mice, which are highly susceptible to B. pseudomallei, Syrian hamsters, and various
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human cell lines (5). More studies relating this model to in vivo infection models need to be
performed. Facultative intracellular bacteria are commonly able to invade, survive and replicate
within amoeba. For pathogens that co-exist naturally with amoeba like B. pseudomallei, it is
worthwhile to further study the effects of these interactions on virulence and persistence in the
environment. The fact that several bacteria, such as L. pneumophila, M. avium and F. tularensis
have been shown to have increased virulence after being passaged with amoeba indicate that life
inside the amoeba activates mechanisms that allow better survival in certain mammalian cells (910, 12). Further work is needed to specifically identify these mechanisms.
Gaining a better understanding of bacterial-amoeba interactions will provide a more complete
picture of the pathogenesis of B. pseudomallei and the host immune response. B. pseudomallei is
able to attach to, enter, and survive within the cell for up to three weeks with or without
encystment, showing the stability of this organism. More importantly, it can use the free-living
amoeba to enhance its pathogenic abilities in mammalian cells, indicating an important role of
free-living amoeba in pathogenesis.
In conclusion, it was found that different B. pseudomallei isolates have varying levels of
virulence, however, the optimal entry time into amoeba is ~3 hr for all ten virulent isolates
assayed. Unlike F. tularensis, B. pseudomallei does not require amoeba encystment to survive.
We showed survival for up to three weeks when amoeba encystment was blocked. Finally, the
virulence of B. pseudomallei in a human monocyte cell-line was increased following passage
through amoeba. The mechanisms involved in this phenomenon are presently unknown and will
be the subject of future studies.
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Table 1 Burkholderia strains used in this study.
Number

Organism

Isolate

1

Burkholderia
pseudomallei
Burkholderia
pseudomallei
Burkholderia
pseudomallei
Burkholderia
pseudomallei
Burkholderia
pseudomallei
Burkholderia
pseudomallei
Burkholderia
pseudomallei
Burkholderia
pseudomallei
Burkholderia
pseudomallei
Burkholderia
pseudomallei
Burkholderia
thailandensis

2
3
4
5
6
7
8
9
10
11

Source

Origin Date

PHLS 6

Country of
Origin
Bangladesh

Human

1960

PHLS 9

Pakistan

Human

1988

PHLS 20

Thailand

Human-blood

1990

PHLS 35

Vietnam

Human

1963

PHLS 66

Kenya

Human-blood

1980

PHLS 4075

Holland

1999

Darwin 2

Australia

Humansputum
Human-blood

2000

80800117

Utah, USA

Human-blood

2008

98/SID 3292

Human

1998

13178

United
Kingdom
Australia

Human

~2002

700388

Thailand

Rice field soil

1994
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% Cell Association

70
60
50
40
30
20
10
0

% Entry

0.025
0.02
0.015
0.01
0.005
0

% Survival

A.

90
80
70
60
50
40
30
20
10
0

700388

13178

98/SID 3292

80800117

Darwin 2

PHLS 4075

PHLS 66

PHLS 35

PHLS 20

PHLS 9

PHLS 6

B.

700388

13178

98/SID 3292

80800117

Darwin 2

PHLS 4075

PHLS 66

PHLS 35

PHLS 20

PHLS 9

PHLS 6

C.

Figure 1. Cell association (A), entry (B) and intracellular survival (C) of B. pseudomallei in A. castellanii cell
cultures. Isolate B. thailandensis 700388 was used as a control. Numbers shown are the percentage of bacteria at
the time of sampling relative to the time zero inoculum. Isolate numbers are displayed on the x-axis. All assays
were performed in triplicate.
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6

5

% Entry

4

3
B. pseudomallei
B. thailandensis
2

1

0
1

2

3

4

Time (hours)

Fig 2. Entry time kinetics of B. pseudomallei and B. thailandensis in A. castellanii cells. Numbers shown are the
percentage of bacteria at the time of sampling relative to the time zero inoculum. Time points in hours are displayed
on the x-axis. All assays were performed in triplicate.
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5
4.5
4
3.5

% Entry

3
2.5
2
1.5
1
0.5
0

Figure 3. A. castellanii entry percentage of ten B. pseudomallei isolates and B. thailandensis 700388 after 3 hr of
co-culture. Numbers shown are the percentage of bacteria after 3 hr relative to the time zero inoculum. Isolate
numbers are listed on the x-axis. All assays were performed in triplicate.

32

A.

% Cell Association

10
8
6
4
2
0
BP

BT

BP

BT

B.
0.7
0.6
% Entry

0.5
0.4
0.3
0.2
0.1
0

C.
1200

% Survival

1000
800
600
400
200
0
BP

BT

Figure 4. Cell association (A), entry (B) and survival (C) of non-passaged B. pseudomallei and B. thailandensis in
the THP1 human monocyte line. BP is B. pseudomallei 13178 and BT is B. thailandensis 700388. Numbers shown
are a percentage of bacteria at time of sampling relative to the time zero inoculum. All assays were performed in
duplicate.
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A.

% Cell Association

350
300
250
200
150
100
50
0
BP

BT

% Entry

B.
350
300
250
200
150
100
50
0
BP

BT

C.

% Survival

2000000
1500000
1000000
500000
0
BP

BT

Figure 5. Cell association (A), entry (B) and survival (C) of amoeba-passaged B. pseudomallei and B. thailandensis
in the THP1 human monocyte line. BP is B. pseudomallei 13178 and BT is B. thailandensis 700388. Numbers
shown are a percentage of the bacteria at time of sampling relative to the time zero inoculum. All assays were
performed in duplicate.
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Table 2 Long-term survival of select isolates of B. pseudomallei and B. thailandensis in A.
castellanii

B. pseudomallei
Time
(days)
3
7
14
21

PHLS 6
‐C
+
+
+
+

*

+C
+
+
+
+

ŧ

PHLS 9

13178

80800117

‐C
+
+
+
+

‐C
+
+
+
+

‐C
+
+
+
+

+C
+
+
+
+

+C
+
+
+
+

*

Amoeba cysts treated only with kanamycin.

ŧ

Amoeba cysts treated with cycloheximide and kanamycin.

†

UI = Uninfected controls

35

+C
+
+
+
+

B.
thailandensis

UI†

700388

‐‐

‐C
+
+
+
+

+C
+
+
+
+

‐C
‐
‐
‐
‐

+C
‐
‐
‐
‐
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